ORENCIA (also known as Abatacept)
Orencia is an antibody modified to prevent full activation of T cells. As an immunomodulator, Orencia has been a helpful treatment for various autoimmune conditions.
- Active, moderate-to-severe rheumatoid arthritis (adults)
- Active, moderate-to-severe polyarticular juvenile idiopathic arthritis (also known as “juvenile rheumatoid arthritis”) (age >= 6)
- Active psoriatic arthritis.
Patients with history of recurrent infections and/or COPD should consult with their physicians prior to starting on Orencia.
Orencia is typically administered as a 30 minute infusion every 2 weeks for the first 3 doses and every 4 weeks thereafter.